Conservative Treatment of Early Adhesive Capsulitis

Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Sep 11, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of conservative treatment methods for early adhesive capsulitis, commonly known as frozen shoulder. The aim is to find out how well these non-surgical treatments work in helping patients regain movement and reduce pain. The trial is currently looking for participants who are aged between 40 and 80 years, have been diagnosed with this condition for less than three months, and have significant limitations in shoulder movement.

To be eligible for the study, participants should not have had any previous shoulder surgeries or other serious health conditions that could interfere with the trial. If you join, you can expect to receive either manual therapy or home rehabilitation exercises, and you'll be monitored over time to see how well these treatments are helping your shoulder. This trial is an important step in understanding the best ways to treat frozen shoulder without surgery, and your involvement could help improve care for others facing similar challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients in our hospital who need manual release of periarthritis of shoulder or home rehabilitation treatment;
• • Unilateral and primary periarthritis of shoulder
• • Age ≥40 years old and ≤80 years old, regardless of gender.
• • Forward flexion movement is more than 50% limited compared with the contralateral.
• • Duration of disease ≤3 months
• Exclusion Criteria:
• • Patients with a previous history of shoulder joint surgery
• • Patients who did not complete the follow-up within the specified time
• • Patients with other shoulder diseases.
• • Patient with systemic immune disease.
• • Patients who have participated in clinical trials or are conducting other clinical trials within 3 months before screening
• • Patients with serious primary cardiovascular diseases, lung diseases, endocrine and metabolic diseases, or serious diseases affecting their survival, such as tumor or AIDS, are considered not suitable for admission.
• • Patients with serious liver diseases, kidney diseases, hematological diseases, such as kidney function (BUN, Cr) more than the upper limit of normal, liver function (ALT, AST, TBIL) more than 2 times the upper limit of normal.
• • Patients with viral hepatitis, infectious diseases, abnormal blood coagulation mechanism and other diseases that researchers consider inappropriate for surgery.
• • Pregnant or lactating women, or those planning to get pregnant during the test, with positive urine HCG test results before the test; Menstruating women should wait until their period is over before undergoing surgery.
• • Patients with severe neurological and mental diseases.
• • Suspected or true history of alcohol and drug abuse.